{{Rsnum
|rsid=10883782
|Chromosome=10
|position=104583932
|Orientation=plus
|GMAF=0.1465
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=132
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 73.5 | 22.1 | 4.4
| HCB | 70.8 | 27.7 | 1.5
| JPT | 73.5 | 23.0 | 3.5
| YRI | 84.4 | 15.0 | 0.7
| ASW | 80.7 | 19.3 | 0.0
| CHB | 70.8 | 27.7 | 1.5
| CHD | 70.6 | 26.6 | 2.8
| GIH | 75.2 | 24.8 | 0.0
| LWK | 77.3 | 20.9 | 1.8
| MEX | 72.4 | 25.9 | 1.7
| MKK | 75.6 | 23.1 | 1.3
| TSI | 56.9 | 39.2 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21627810
|Title=Estrogen and progesterone-related gene variants and colorectal cancer risk in women
|OA=1
}}

{{PMID Auto
|PMID=19015200
|Title=Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer.
|OA=1
}}

{{PMID Auto
|PMID=21229561
|Title=CYP17 gene polymorphisms and prostate cancer risk: A meta-analysis based on 38 independent studies.
}}

{{PMID Auto
|PMID=21656827
|Title=CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}